In this webinar, Steve and Naheed present the latest advances in genomics, the impact on drug target discovery, and how combinatorial analytics is being applied to finding new treatment approaches for patients with unmet medical needs in a wide range of chronic diseases.
WEBINAR: Disease Mechanisms and Novel Target Discovery
Watch on-demand as PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji, exploring Disease Mechanisms and Novel Target Discovery.
Steve Gardner, PhD
CEO & Co-founder of PrecisionLife
Co-Founder/President/CEO at Cyclica Inc.
Ask us a question or contact us to discuss potential collaborations and partnership opportunities, by sending us a message here and we'll get back to you as soon as we can.